Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05531656

1 development in the corpus

NCT05531656

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 2 TRIAL

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

ClinicalTrials.gov

Phase 2 trial with cognitive endpoint in early Alzheimer's disease; results not yet reported in this registry record, so no efficacy or safety data can be evaluated.

PreliminaryCognition Therapeutics Early Alzheimer's Disease NCT05531656

Reported

Planned enrollment540

PhasePhase 2

Primary outcome measureChange from baseline in Clinical Dementia R…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support